International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

PreScription: Endemics, Epidemics, and Pandemics

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2021 - Volume 25, Number 4
View All Articles in Issue

Page(s): 268

PreScription: Endemics, Epidemics, and Pandemics Page 1

Download in electronic PDF format for $65

Abstract:

Related Keywords: Loyd V. Allen Jr., PhD, RPh, endemic, pandemic, epidemic, COVID-19, infectious diseases

Related Categories: HISTORY, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PreScription: Endemics, Epidemics, and Pandemics Allen Loyd V Jr	Jul/Aug 2021 Pg. 268
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic McElhiney Linda F	Jul/Aug 2020 Pg. 287-295
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
PreScription: COVID-19 and Compounding Pharmacists Allen Loyd V Jr	Jul/Aug 2020 Pg. 268
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants Riepl Mike	Jan/Feb 2023 Pg. 12-21
Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment Riepl Mike	Mar/Apr 2023 Pg. 98-107
Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol	Sep/Oct 2020 Pg. 358-364
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development Riepl Mike, Kaiser Joe	May/Jun 2023 Pg. 192-200
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B	Mar/Apr 2021 Pg. 109-113
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
The Treatment of Canine Atopic Disease Davidson Gigi S	May/Jun 2002 Pg. 210-215
Treating Canine Hepatic Disease Davidson Gigi S	May/Jun 2003 Pg. 188-191
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Allen Loyd V Jr	Jul/Aug 2020 Pg. 316
Calculations Stockton Shelly J	Jul/Aug 2020 Pg. 310
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
Compounding for Treatment of Equine Infectious Diseases: An Overview Bramwell Bethany L	Nov/Dec 2011 Pg. 450-457
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Brunner Scott	Jul/Aug 2021 Pg. 296-297
It's Time for a New Philosophy Brunner Scott	Sep/Oct 2021 Pg. 386-387
Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh Vail Jane	Jan/Feb 2002 Pg. 16-18
Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Okeke Claudia C, Allen Loyd V Jr	May/Jun 2010 Pg. 232-238